Synthesis, characterization and stability of dendrimer prodrugs.

The design, synthesis and characterization of a series of zero generation (G0) PAMAM dendrimer-based prodrugs for the potential enhancement of drug solubility and bioavailability are described. Naproxen, a poorly water-soluble drug, was conjugated to dendrimers either directly by an amide bond or by ester bonds using either L-lactic acid or diethylene glycol as a linker. All of the prodrugs were more hydrophilic than the parent drug, as evaluated by drug partitioning between 1-octanol and phosphate buffer (pH 7.4). Hydrolysis of the conjugates was measured at 37 degrees C in hydrochloric acid buffer (pH 1.2), phosphate buffer (pH 7.4), borate buffer (pH 8.5) and in 80% human plasma. The amide conjugate and both ester conjugates were chemically stable at all pHs over 48 h of incubation. Naproxen was enzymatically released from both ester conjugates in plasma; the lactic ester conjugate hydrolyzed slowly with only 25% of naproxen released after 24h, the diethylene glycol ester conjugate cleaved rapidly following pseudo first order kinetics (t(1/2) = 51 min). G0 PAMAM dendrimer prodrugs with an appropriate linker (diethylene glycol) show good potential as carriers for oral delivery.

[1]  F. Szoka,et al.  Polyester dendritic systems for drug delivery applications: design, synthesis, and characterization. , 2002, Bioconjugate chemistry.

[2]  Neil B. McKeown,et al.  Engineering of Dendrimer Surfaces to Enhance Transepithelial Transport and Reduce Cytotoxicity , 2003, Pharmaceutical Research.

[3]  Antony D'Emanuele,et al.  The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Steve P. Rannard,et al.  Dendrimers: a new class of nanoscopic containers and delivery devices , 2003 .

[5]  Antony D'Emanuele,et al.  Dendrimer-drug interactions. , 2005, Advanced drug delivery reviews.

[6]  H. Ghandehari,et al.  Transport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers. , 2003, International journal of pharmaceutics.

[7]  James R. Dewald,et al.  A New Class of Polymers: Starburst-Dendritic Macromolecules , 1985 .

[8]  A T Florence,et al.  Oral uptake and translocation of a polylysine dendrimer with a lipid surface. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[9]  M. G. Rimoli,et al.  In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenac. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[10]  S. Kannan,et al.  Synthesis, cellular transport, and activity of polyamidoamine dendrimer-methylprednisolone conjugates. , 2005, Bioconjugate chemistry.

[11]  Hamidreza Ghandehari,et al.  Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[12]  E. Meijer,et al.  Encapsulation of Guest Molecules into a Dendritic Box , 1994, Science.

[13]  R. Zhuo,et al.  In vitro release of 5-fluorouracil with cyclic core dendritic polymer. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[14]  H. Nakanishi,et al.  Synthesis and biological studies of 5-aminolevulinic acid-containing dendrimers for photodynamic therapy. , 2001, Bioconjugate chemistry.

[15]  N. McKeown,et al.  The influence of surface modification on the cytotoxicity of PAMAM dendrimers. , 2003, International journal of pharmaceutics.

[16]  Ruth Duncan,et al.  Anionic PAMAM Dendrimers Rapidly Cross Adult Rat Intestine In Vitro: A Potential Oral Delivery System? , 2000, Pharmaceutical Research.

[17]  R. Wiwattanapatapee,et al.  Dendrimers conjugates for colonic delivery of 5-aminosalicylic acid. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[18]  K. Kono,et al.  Design of dendritic macromolecules containing folate or methotrexate residues. , 1999, Bioconjugate chemistry.

[19]  J. Swarbrick,et al.  Encyclopedia of Pharmaceutical Technology , 2006 .

[20]  D. Meijer,et al.  Low molecular weight proteins as carriers for renal drug targeting. Preparation of drug-protein conjugates and drug-spacer derivatives and their catabolism in renal cortex homogenates and lysosomal lysates. , 1992, Journal of medicinal chemistry.